|
Treatment of Cardio Vascular Disease with low dose Rivaroxaban in Advanced Chronic Kidney Disease(TRACK)
|
Ongoing
|
Rivaroxaban
|
3
|
SCT21R/008/10
|
King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah),King Khalid University Hospital (Riyadh)
|
|
Comparison of Three Times of Thyroid Hormone Replacement During Fasting the Month of Ramadan Among Patients with Total Thyroidectomy in Saudi Population: A Randomized Controlled Trial.
|
Ongoing
|
levothyroxine
|
4
|
E-21-5765
|
King Khalid University Hospital (Riyadh)
|
|
Ceftazidime-Avibactam versus Colistin in Critically Ill Patients with Carbapenem-Resistant Enterobacteriaceae Infections (AVI-ICU): A Randomized Clinical Trial
|
Ongoing
|
Ceftazidime-avibactam
|
3
|
2211247
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated with Complement Inhibitors
|
Ongoing
|
Crovalimab
|
3
|
BO42161
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Phase III, Randomized, Open-Label, Active-Controlled, Multicenter Study Evaluating The Efficiacy And Safety Of Crovalimab Versus Eculizumab In Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
|
Completed
|
Crovalimab
|
3
|
BO42162
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma (CARTITUDE-2)
|
Ongoing
|
Carvkti
|
2
|
68284528MMY2003
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Minimal Effective Concentration of Lidocaine in Propofol Lidocaine Mixture for Relief of Pain on Propofol Injection
|
Rejected
|
lidocaine
|
4
|
IRB-2020-3
|
King Fahad University Hospital (Al-Khobar)
|
|
A Prospective, Multicenter, Single-Arm, Open-Label, Phase 3 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE)
|
Completed
|
Selexipag
|
3
|
67896049PAH4005
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A randomised, double-blind, placebo-controlled trial of erythropoietin alfa versus placebo in mechanically ventilated critically ill patients following traumatic injury
|
Ongoing
|
Epoetin Alfa (Recombinant Human Erythropoietine) (EPREX)
|
3
|
EPO-TRAUMA ANZIC-RC/CF001 - CT20/046/R
|
King Abdulaziz Medical City NG (Riyadh)
|
|
An Open-label Extension Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial
|
Ongoing
|
Inclacumab
|
3
|
GBT2104-133
|
Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabi
|
